Home › Kanser sa Pancreas
Pag-aaral pangklinika para sa Kanser sa Pancreas na nagre-recruit sa U.S.
248 pag-aaral para sa Kanser sa Pancreas ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX59 pag-aaral
- New York City, NY57 pag-aaral
- Boston, MA42 pag-aaral
- Nashville, TN39 pag-aaral
- Los Angeles, CA36 pag-aaral
- Arlington, VA33 pag-aaral
- San Antonio, TX33 pag-aaral
- St. Louis, MO33 pag-aaral
- Baltimore, MD30 pag-aaral
- Philadelphia, PA26 pag-aaral
- Tampa, FL26 pag-aaral
- San Diego, CA24 pag-aaral
- Durham, NC24 pag-aaral
- Queens, NY23 pag-aaral
- Atlanta, GA22 pag-aaral
- Seattle, WA22 pag-aaral
- Dallas, TX22 pag-aaral
- Chicago, IL21 pag-aaral
- Jacksonville, FL21 pag-aaral
- Rochester, MN20 pag-aaral
- Washington, DC20 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Portland, OR19 pag-aaral
- Grand Rapids, MI19 pag-aaral
- Pittsburgh, PA19 pag-aaral
- San Francisco, CA19 pag-aaral
- Edison, NJ18 pag-aaral
- Phoenix, AZ18 pag-aaral
- Milwaukee, WI18 pag-aaral
- Columbus, OH18 pag-aaral
- Cleveland, OH16 pag-aaral
- Omaha, NE15 pag-aaral
- Orange, CA15 pag-aaral
- New Haven, CT15 pag-aaral
- Salt Lake City, UT14 pag-aaral
- Ann Arbor, MI14 pag-aaral
- Miami, FL13 pag-aaral
- Denver, CO13 pag-aaral
- Scottsdale, AZ13 pag-aaral
- Birmingham, AL12 pag-aaral
Ayos sa estado
- Alabama13 pag-aaral
- Alaska4 pag-aaral
- Arizona33 pag-aaral
- Arkansas10 pag-aaral
- California88 pag-aaral
- Colorado25 pag-aaral
- Connecticut24 pag-aaral
- Delaware7 pag-aaral
- District of Columbia10 pag-aaral
- Florida62 pag-aaral
- Georgia24 pag-aaral
- Hawaii7 pag-aaral
- Idaho4 pag-aaral
- Illinois32 pag-aaral
- Indiana11 pag-aaral
- Iowa7 pag-aaral
- Kansas12 pag-aaral
- Kentucky12 pag-aaral
- Louisiana11 pag-aaral
- Maine3 pag-aaral
- Maryland43 pag-aaral
- Massachusetts46 pag-aaral
- Michigan37 pag-aaral
- Minnesota33 pag-aaral
- Mississippi5 pag-aaral
- Missouri38 pag-aaral
- Montana6 pag-aaral
- Nebraska15 pag-aaral
- Nevada7 pag-aaral
- New Hampshire4 pag-aaral
- New Jersey27 pag-aaral
- New Mexico6 pag-aaral
- New York67 pag-aaral
- North Carolina34 pag-aaral
- North Dakota6 pag-aaral
- Ohio42 pag-aaral
- Oklahoma12 pag-aaral
- Oregon19 pag-aaral
- Pennsylvania39 pag-aaral
- Rhode Island7 pag-aaral
- South Carolina12 pag-aaral
- South Dakota7 pag-aaral
- Tennessee44 pag-aaral
- Texas79 pag-aaral
- Utah24 pag-aaral
- Vermont3 pag-aaral
- Virginia42 pag-aaral
- Washington26 pag-aaral
- West Virginia6 pag-aaral
- Wisconsin28 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07522073A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07644559High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05053555Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05053971Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01950572Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Nagre-recruit
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04907643Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01174121A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07458347Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05372614A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07020221Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03492671Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04222413Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07325214Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07562152Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06141031Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07805954The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07621718Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06807437CREO - Microwave Ablation Feasibility Study
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07817147Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07828236A 2-part Phase 1/2 Open-label Trial on ODM-212
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07563738A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07090499INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
Nagre-recruitMay bayad para sa mga kalahok
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07671937Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05132504Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.